DrugPatentWatch Database Preview

Details for Patent: 7,858,662

« Back to Dashboard

Which drugs does patent 7,858,662 protect, and when does it expire?

Patent 7,858,662 protects VEREGEN and is included in one NDA.

This patent has twenty-nine patent family members in twenty countries.

Summary for Patent: 7,858,662

Title:	Medicament for the treatment of viral skin and tumour diseases
Abstract:	The invention relates to a medicament containing a compound of general formula (1), where R.sub.1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C.sub.11-C.sub.21 alkyl, alkylene or alkynyl group, preferably a C.sub.11-C.sub.15 alkyl, alkylene or alkynyl group, particularly a C.sub.11-C.sub.13 alkyl, alkylene or alkynyl group, most preferably a C.sub.13 alkyl group, R2=independently, a straight or branched C.sub.1-C.sub.8 alkyl, alkylene or alkynyl group, preferably a C.sub.1-C.sub.6 alkyl, alkylene or alkynyl group, in particular a C.sub.2-C.sub.4 alkyl, alkylene or alkynyl group, most preferably a C.sub.3 alkyl group, a --[CH.sub.2--(CH.sub.2).sub.m--O].sub.nH group with n=1 to 10, preferably n=1 to 5, m=1 to 5, preferably m=1 to 3, a --CH.sub.2--[CH--(OH)].sub.p[CH.sub.2--(R.sub.3)]-- group, where R.sub.3=independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof. ##STR00001##
Inventor(s):	Chang; Yunik (Sonoma, CA), Lathrop; Robert (Fort Collins, CO), Bohm; Erwin (Ladenburg, DE), Gander-Meisterernst; Irene (Stockdorf, DE), Greger; Regina (Iffeldorf, DE), Holldack; Johanna (Ebeltoft, DK), Moebius; Ulrich (Gauting-Unterbrunn, DE)
Assignee:	MediGene AG (Planegg, DE)
Application Number:	10/495,889
Patent Claim Types: see list of patent claims	Compound; Formulation; Use;

Drugs Protected by US Patent 7,858,662

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Fougera Pharms Inc	VEREGEN	sinecatechins	OINTMENT;TOPICAL	021902-001	Oct 31, 2006		RX	Yes	Yes			Y			TREATMENT OF GENITAL WARTS

Foreign Priority and PCT Information for Patent: 7,858,662

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	101 56 794	Nov 19, 2001

PCT Information
PCT Filed	November 18, 2002	PCT Application Number:	PCT/EP02/12919
PCT Publication Date:	May 30, 2003	PCT Publication Number:	WO03/043628

Non-Orange Book US Patents Family Members for Patent 7,858,662

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
9,770,406	Medicament for the treatment of viral skin and tumour diseases

International Patents Family Members for US Patent 7,858,662

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Russian Federation	2302861
Russian Federation	2004118667
Portugal	1448186
Mexico	PA04004532